Drug intelligence / Profile preview

licoricidin

Development stage
Preclinical
Lead developer
Hallym University
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Licoricidin (also known as licorisoflavan B) is a bioactive prenylated isoflavonoid (specifically a hydroxyisoflavan) isolated from the roots of licorice plants, such as *Glycyrrhiza glabra* and *Glycyrrhiza uralensis*. It exhibits a wide range of pharmacological activities, including anti-inflammatory, antibacterial, antiangiogenic, and antimetastatic properties. In preclinical studies, licoricidin has demonstrated significant antitumor efficacy against various cancer types, including breast, gastric, colorectal, prostate, and cervical cancers, often by inducing apoptosis, cell cycle arrest, and inhibiting cell migration and invasion. It has also been investigated for its neuroprotective effects in traumatic brain injury models and its potential as an active ingredient in topical anti-aging formulations due to its reactive oxygen species (ROS) scavenging and matrix metalloproteinase-1 (MMP-1) inhibitory activities.

Other names
(+)-licoricidin7-O-demethyllicorisoflavan Alicorisoflavan B
02

Targets

ELANE (Human Neutrophil Elastase)ICMT (Isoprenylcysteine carboxyl methyltransferase)MMP2 (Matrix metalloproteinase-2)MMP7 (Matrix metallopeptidase 7)MMP8 (Neutrophil collagenase)MMP9 (Matrix metalloproteinase-9)RELA (Nuclear Factor Kappa B Subunit p65)VCAM1 (Vascular cell adhesion molecule 1)ElastaseMMP1 (Matrix metalloproteinase-1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)SIRT3 (NAD-dependent protein deacetylase sirtuin-3)

Beyond the preview

Go deeper on licoricidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on licoricidin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call